58 results on '"Adelstein, David J."'
Search Results
2. Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design
3. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging
4. Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer
5. Chemotherapy in the definitive management of oral cancers: Where do we stand today?
6. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
7. Response to ASTRO consensus guideline for oropharyngeal cancer
8. Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆
9. Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline
10. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis
11. Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11
12. Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer
13. A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction
14. Enteral Feeding Tubes in Patients Undergoing Definitive Chemoradiation Therapy for Head-and-Neck Cancer: A Critical Review
15. Biology and Management of Salivary Gland Cancers
16. Clinical trial design in head and neck cancer: what has the oncologist learned?
17. Role of positron emission tomography in management of sinonasal neoplasms—a single institution's experience
18. Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution
19. PD25. Role of human papillomavirus (HPV) biomarkers in head and neck squamous cell cancer and implications for clinical practice
20. K2. Clinical trial design in head and neck cancer: Lessons learned and challenges for the future
21. Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization
22. Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy
23. A Phase II Study of Perioperative Concurrent Chemotherapy, Gefitinib, and Hyperfractionated Radiation Followed by Maintenance Gefitinib in Locoregionally Advanced Esophagus and Gastroesophageal Junction Cancer
24. Gender, Race, and Survival: A Study in Non–Small-Cell Lung Cancer Brain Metastases Patients Utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification
25. Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction
26. Induction Chemoradiotherapy Increases Pleural and Pericardial Complications after Esophagectomy for Cancer
27. Utility of Positron Emission Tomography Compared With Mediastinoscopy for Delineating Involved Lymph Nodes in Stage III Lung Cancer: Insights for Radiotherapy Planning From a Surgical Cohort
28. Current and Emerging Standards of Concomitant Chemoradiotherapy
29. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)
30. Concurrent Chemoradiotherapy in the Management of Squamous Cell Cancer of the Oropharynx: Current Standards and Future Directions
31. T2N0M0 esophageal cancer
32. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer–only brain metastases
33. Brain Metastases From Esophageal Cancer: A Phenomenon of Adjuvant Therapy?
34. Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer
35. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma
36. Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer
37. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma
38. Refining esophageal cancer staging
39. Stage III non–small cell lung cancer and metachronous brain metastases
40. Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer
41. Superficial adenocarcinoma of the esophagus
42. Esophageal carcinoma: Importance and associations of N1 burden
43. N1 esophageal carcinoma: The importance of staging and downstaging
44. The Role of Chemotherapy for Skull Base Carcinomas and Sarcomas
45. M1a/M1b esophageal carcinoma: Clinical relevance
46. INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER
47. Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer
48. Esophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status
49. Treatment of head and neck cancer: the role of chemotherapy
50. Stage II esophageal carcinoma: The significance of T and N
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.